What is the ideal timing for preeclampsia screening using uterine‑artery Doppler velocimetry?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ideal Timing for Preeclampsia Screening Using Uterine Artery Doppler Velocimetry

For high-risk women, perform uterine artery Doppler screening at 18-24 weeks' gestation (specifically at 20-24 weeks alongside the routine fetal anomaly scan), and do not repeat it later in the second trimester as this provides limited additional value. 1

Risk-Based Screening Approach

First Trimester (11-14 weeks)

  • Uterine artery Doppler can be incorporated into first-trimester screening algorithms when combined with maternal risk factors, blood pressure, and placental growth factor 2
  • However, first-trimester uterine artery Doppler alone has insufficient predictive ability to be clinically useful as a standalone screening test 1, 3
  • The ISSHP supports first-trimester screening when integrated into local health systems, though cost-effectiveness remains unestablished 2

Second Trimester (18-24 weeks) - OPTIMAL TIMING

This is the most clinically useful window for uterine artery Doppler screening in high-risk populations:

  • Perform at 18+0 to 24+6 weeks (ideally 20-24 weeks) alongside the routine fetal anomaly scan 1
  • At this timing, uterine artery Doppler combined with maternal factors and fetal biometry can detect 89% of very preterm SGA below the 5th centile with a 10% false positive rate 1
  • Mean uterine artery pulsatility index (PI) ≥95th centile is the recommended measurement parameter 1

Clinical Decision Algorithm Based on Second Trimester Results:

If mean uterine artery PI is NORMAL (≤95th centile):

  • Risk of placental dysfunction, hypertensive disorders, and early-onset FGR is low 1
  • Commence serial fetal biometry scanning in the third trimester starting at 32 weeks 1

If mean uterine artery PI is ABNORMAL (>95th centile):

  • Commence serial scanning earlier at 24+0 to 28+6 weeks, determined individually 1
  • Do NOT repeat uterine artery Doppler later in the second trimester - this provides limited additional value even though some abnormal results may normalize 1

Why Not Other Timings?

Third Trimester

  • Third-trimester uterine artery Doppler is NOT an effective risk assessment tool in unselected pregnancies 1
  • It has moderate utility only when FGR is already suspected, but not as a standalone screening test 1

Low-Risk Populations

  • Uterine artery Doppler screening is NOT recommended for routine use in low-risk women 3
  • A recent publication specifically did not support second-trimester maternal uterine artery evaluation as a screening tool in low-risk women 3
  • The ACR Appropriateness Criteria found no trials supporting its use as an FGR screening tool in low-risk populations 3

Key Clinical Pitfalls to Avoid

  1. Don't screen low-risk women - The evidence consistently shows poor sensitivity and lack of clinical utility in unselected populations 3, 4

  2. Don't repeat Doppler in late second trimester - While some abnormal results normalize, repeating at 28+ weeks adds limited value and those with normalization still carry increased risk 1

  3. Don't use uterine artery Doppler as the sole screening method - It should be combined with maternal risk factors, blood pressure measurements, and biomarkers for optimal prediction 2, 1

  4. Recognize the primary benefit - Much of the utility of uterine artery Doppler screening for FGR comes from identifying women at risk for early-onset preeclampsia rather than FGR itself 1

Supporting Evidence Quality

The most recent and highest-quality evidence comes from the 2024 BJOG Green-Top Guideline 1, which provides Grade B recommendations based on Level 2++ evidence. This is supported by the 2018 ISSHP guidelines 2 and multiple international consensus statements 5. Recent research from 2025 6 confirms that performance at 18-22 weeks in high-risk pregnancies is excellent for predicting early-onset preeclampsia and early-onset SGA with NPV >97%.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.